Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-049119

Chief Medical Officer sold 17,500 shares at $18.04 ($315,700)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2018-08-29 Sale −17,500 $18.04 $315,700 218,390 I: show line 1 in the form
Open-market sales · 17,500 sh · avg $18.04 · $315,700
Loading xslF345X03/doc4.xml…